This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04652/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04652/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB04652/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB04652/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04652/identifier/pubchem-compound/

Statements

Subject Item
n2:DB04652
rdf:type
n9:Drug
n9:description
An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
n9:group
experimental
owl:sameAs
n6:DB04652 n13:DB04652
dcterms:title
(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE
adms:identifier
n4:C0R n7:5753 n8:5550 n11:DB04652 n14:46504547
n9:IUPAC-Name
n10:271B46ED-363D-11E5-9242-09173F13E4C5
n9:InChI
n10:271B46F3-363D-11E5-9242-09173F13E4C5
n9:Molecular-Formula
n10:271B46F2-363D-11E5-9242-09173F13E4C5
n9:Molecular-Weight
n10:271B46EF-363D-11E5-9242-09173F13E4C5
n9:Monoisotopic-Weight
n10:271B46F0-363D-11E5-9242-09173F13E4C5
n9:SMILES
n10:271B46F1-363D-11E5-9242-09173F13E4C5
n9:Water-Solubility
n10:271B46EB-363D-11E5-9242-09173F13E4C5
n9:logP
n10:271B46E9-363D-11E5-9242-09173F13E4C5 n10:271B46EC-363D-11E5-9242-09173F13E4C5
n9:logS
n10:271B46EA-363D-11E5-9242-09173F13E4C5
n9:H-Bond-Acceptor-Count
n10:271B46F9-363D-11E5-9242-09173F13E4C5
n9:H-Bond-Donor-Count
n10:271B46FA-363D-11E5-9242-09173F13E4C5
n9:InChIKey
n10:271B46F4-363D-11E5-9242-09173F13E4C5
n9:Polar-Surface-Area--PSA-
n10:271B46F5-363D-11E5-9242-09173F13E4C5
n9:Polarizability
n10:271B46F7-363D-11E5-9242-09173F13E4C5
n9:Refractivity
n10:271B46F6-363D-11E5-9242-09173F13E4C5
n9:Rotatable-Bond-Count
n10:271B46F8-363D-11E5-9242-09173F13E4C5
n9:Bioavailability
n10:271B46FF-363D-11E5-9242-09173F13E4C5
n9:Ghose-Filter
n10:271B4701-363D-11E5-9242-09173F13E4C5
n9:MDDR-Like-Rule
n10:271B4702-363D-11E5-9242-09173F13E4C5
n9:Number-of-Rings
n10:271B46FE-363D-11E5-9242-09173F13E4C5
n9:Physiological-Charge
n10:271B46FD-363D-11E5-9242-09173F13E4C5
n9:Rule-of-Five
n10:271B4700-363D-11E5-9242-09173F13E4C5
n9:Traditional-IUPAC-Name
n10:271B46EE-363D-11E5-9242-09173F13E4C5
n9:pKa--strongest-acidic-
n10:271B46FB-363D-11E5-9242-09173F13E4C5
n9:pKa--strongest-basic-
n10:271B46FC-363D-11E5-9242-09173F13E4C5